Skip to main content
. Author manuscript; available in PMC: 2008 Oct 6.
Published in final edited form as: Ophthalmology. 2007 Aug 2;115(4):693–699. doi: 10.1016/j.ophtha.2007.05.038

Table 3.

Combined Effect* of LOC387715 Genotypes and Hemostatic Factors on the Risk of Age-Related Macular Degeneration (AMD)

Any AMD
Early AMD
Late AMD
LOC387715 Genotype Lower 2 Tertiles Highest Tertile Lower 2 Tertiles Highest Tertile Lower 2 Tertiles Highest Tertile
Fibrinogen
G/G 1.0 0.89 (0.59–1.35) 1.0 0.94 (0.60–1.46) 1.0 0.68 (0.28–1.67)
G/T + T/T 1.79 (1.25–2.56) 1.54 (0.98–2.43) 1.75 (1.19–2.57) 1.50 (0.92–2.45) 1.90 (0.95–3.78) 1.70 (0.73–3.97)
Homocysteine
G/G 1.0 1.50 (0.99–2.29) 1.0 1.30 (0.82–2.06) 1.0 2.65 (1.15–6.12)
G/T + T/T 2.13 (1.48–3.07) 1.67 (1.05–2.67) 1.95 (1.33–2.87) 1.48 (0.89–2.46) 3.42 (1.54–7.60) 2.79 (1.12–6.93)
Plasminogen activator inhibitor 1
G/G 1.0 1.26 (0.78–2.04) 1.0 1.18 (0.70–1.99) 1.0 1.71 (0.63–4.60)
G/T + T/T 1.67 (1.07–2.60) 2.30 (1.31–4.02) 1.47 (0.91–2.37) 2.11 (1.17–3.83) 2.65 (1.11–6.34) 3.49 (1.15–10.59)
von Willebrand factor
G/G 1.0 1.05 (0.64–1.70) 1.0 1.10 (0.65–1.86) 1.0 0.84 (0.30–2.38)
G/T + T/T 1.81 (1.16–2.81) 1.61 (0.93–2.80) 1.63 (1.01–2.63) 1.60 (0.89–2.90) 2.67 (1.14–6.22) 1.63 (0.57–4.70)

Odds ratio (95% confidence interval).

*

All models adjusted for age and current smoking status.